Reich, K., Iversen, L., Puig, L., Lambert, J., Mrowietz, U., Saday, K., & Warren, R. (2022). Long-term efficacy and safety of brodalumab in moderate-to-severe plaque psoriasis: A post hoc pooled analysis of AMAGINE-2 and-3.
Citação norma ChicagoReich, K., L. Iversen, L. Puig, J. Lambert, U. Mrowietz, KK Saday, y RB Warren. Long-term Efficacy and Safety of Brodalumab in Moderate-to-severe Plaque Psoriasis: A Post Hoc Pooled Analysis of AMAGINE-2 And-3. 2022.
Citação norma MLAReich, K., et al. Long-term Efficacy and Safety of Brodalumab in Moderate-to-severe Plaque Psoriasis: A Post Hoc Pooled Analysis of AMAGINE-2 And-3. 2022.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.